Scale/Scope:
2 districts
Evaluation Design:
Repeated cross-sectional – baseline (Nov 2005): 389 women of reproductive age (WRA); 1st follow-up (July 2006): 253 WRA; 2nd follow-up (Sept 2007): 276 WRA; 3rd follow-up (Apr 2009): 322 WRA
Outcomes
Outcomes Measured:
% of women who took at least 75% of tablets received during pregnancy
Results:
3rd follow-up vs. 2nd follow-up vs. 1st follow-up: 87% vs. 90% vs. 51%
P-values/CIs:
95% CIs: (80% - 93%) vs. (84% - 95%) vs. (37% vs. 65%)
Height
Tallest
High Impact Practices:
Intake of micronutrient and iron supplements